Catalyst Biosciences, Inc. (CBIO) Social Stream



Catalyst Biosciences, Inc. (CBIO): $1.92

0.03 (+1.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CBIO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Catalyst Biosciences Inc (CBIO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CBIO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-21 4 $16 $15 $15.666 $0.67 2238.21%
2021-11-12 4 $15 $4 $9.5 $0.67 1317.91%

The Trend in the Analyst Price Target


CBIO's average price target has moved down $6.33 over the prior 161 days.

Over the past 161 days, CBIO's average upside potential has been 316.8%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-04 0 25 15 18.000 4.20 328.57%
2021-08-28 0 18 15 16.600 4.66 256.22%
2021-09-14 0 18 15 16.600 4.79 246.56%
2021-09-21 4 18 15 16.250 4.87 233.68%
2021-09-21 4 16 15 15.666 4.87 221.68%

CBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


Over the past 52 weeks, CBIO's average broker recommendation rating worsened by 0.17.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Catalyst Biosciences Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 399.13% of that group.
  • To contextualize these metrics, consider that out of all US stocks, Catalyst Biosciences Inc's variance in analysts' estimates is lower than -116.38% of them.
  • Catalyst Biosciences Inc's average analyst price target is higher than 87.24% of Healthcare stocks.
  • Catalyst Biosciences Inc's number of analysts covering the stock is greater than 91.92% of Pharmaceutical Products stocks.

Stocks similar to Catalyst Biosciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CBAY, CARA, and CANF.

What is the outlook for CBIO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4033 seconds.